Health TrialsbyHealthPanel

Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

ConditionNephrotic Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14+
SponsorSun Yat-sen University

About this trial

The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. The treatment response, longitudinal changes of renal function, renal survival, patient survival, infection events and acute kidney injury etc, will be analyzed using the NS database.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Nephrotic syndrome patients regardless of the primary causes

Disqualifiers

No

Trial population

Nephrotic syndrome patients

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention

    Other intervention

    Registration of all NS patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.

Treatment groups

5,000 Participants
are divided into 1 treatment group
Group A: Nephrotic syndrome patients1 intervention

Trial outcomes

Primary outcomes

1

The patient survival in NS patients

Time frame
10 years

Secondary outcomes

1

Renal survival in NS patients

Renal survival including end stage renal disease, dialysis, renal transplantation

Time frame
10 years
2

Longitudinal changes of renal function of NS patients

Time frame
10 years
3

Treatment response of NS patients

Time frame
10 years
4

Infection rate of NS patients

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sun Yat-sen University

Lead sponsor

Source ClinicalTrials.gov
Apply now